US Stock MarketDetailed Quotes

AIM AIM ImmunoTech

Watchlist
  • 0.4710
  • +0.0280+6.32%
Close Mar 28 16:00 ET
  • 0.4868
  • +0.0158+3.35%
Post 17:21 ET
23.00MMarket Cap-1095P/E (TTM)

About AIM ImmunoTech Company

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

Company Profile

SymbolAIM
Company NameAIM ImmunoTech
Listing Date07/19/1996
Founded1966
CEOMr. Thomas K. Equels, Esq.
MarketAMEX
Employees24
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2117 SW Highway 484
CityOcala
ProvinceFlorida
CountryUnited States of America
Zip Code34473
Phone1-352-448-7797

Company Executives

  • Name
  • Position
  • Salary
  • Thomas K. Equels, Esq.
  • Executive Vice Chairman of the Board, Chief Executive Officer and President
  • 2.66M
  • Dr. David R. Strayer, M.D.
  • Chief Scientific Officer and Medical Director
  • --
  • Robert Dickey, IV
  • Chief Financial Officer
  • --
  • Peter W. Rodino, III
  • Chief Operating Officer, Executive Director for Governmental Relations, General Counsel and Secretary
  • 793.48K
  • Dr. William M. Mitchell, M.D.,PhD
  • Chairman of the Board
  • 294.62K
  • Nancy K. Bryan
  • Independent Director
  • --
  • Stewart L. Appelrouth
  • Independent Director
  • 294.62K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg